Skip to main content
Top

01-06-2012 | Research Paper

Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2

Authors: Obul R. Bandapalli, Stephan Macher-Goeppinger, Peter Schirmacher, Karsten Brand

Published in: Clinical & Experimental Metastasis | Issue 5/2012

Login to get access

Abstract

In a nude mouse model of colorectal liver metastases, we have identified a paracrine tumor cell/host cell signalling pathway that is apparently required for successful tumor growth. Whereas recombinant platelet derived growth factor-C (PDGF-C) and supernatants from PDGF-C secreting wild type LS174T colon carcinoma cells could rescue tumor promoting hepatic stellate cells (HSC) from growth inhibition by serum starvation, supernatants from LS174T colon carcinoma cells with reduced secretion of PDGF-C had much less effect on serum starved HSC. Autocrine growth inhibition of LS174T cells by PDGF-C knock-down was only marginal. In vivo, a prominent inhibition of liver metastasis was observed if PDGF-C was knocked-down in LS174T cells. By whole genome array analysis of host cells of the invasion front and subsequent immunohistochemical staining we identified p21 activated kinase-2 (PAK-2) as being strongly and specifically expressed by HSC. The above described effect of PDGF-C on HSC was found to be dependent on PAK-2 because in contrast to wild type HSC, silencing of PAK-2 in HSC only allowed for a partial PDGF-C-mediated rescue from serum starvation leading to only a slight increase of proliferation. These data indicate that PDGF-C promotes tumor growth via a growth promoting effect on HSC that is at least in part dependent on the presence of functional PAK-2.
Literature
1.
go back to reference Becker N, Wahrendorf J (1997) Krebsatlas der Bundesrepublik Deutschland. Springer, Berlin Becker N, Wahrendorf J (1997) Krebsatlas der Bundesrepublik Deutschland. Springer, Berlin
2.
go back to reference Grem JL (1991) Current treatment approaches in colorectal cancer. Semin Oncol. 18(1 Suppl 1):17–26 Grem JL (1991) Current treatment approaches in colorectal cancer. Semin Oncol. 18(1 Suppl 1):17–26
3.
go back to reference Curley SA et al. (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metast Rev 23(1–2):165–182 Curley SA et al. (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metast Rev 23(1–2):165–182
4.
go back to reference Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379 Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379
5.
go back to reference Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4(11):839–849 Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4(11):839–849
6.
go back to reference Bandapalli OR et al (2006) Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 118(1):74–89 Bandapalli OR et al (2006) Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 118(1):74–89
7.
go back to reference Bandapalli OR et al (2008) Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens. BMC Genomics 9:448PubMedCrossRef Bandapalli OR et al (2008) Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens. BMC Genomics 9:448PubMedCrossRef
8.
go back to reference Brand K et al (2000) Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60(20):5723–5730 Brand K et al (2000) Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60(20):5723–5730
9.
go back to reference Skobe M, Fusenig NE (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 95(3):1050–1055 Skobe M, Fusenig NE (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 95(3):1050–1055
10.
go back to reference Forsberg K et al (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90(2):393–397 Forsberg K et al (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90(2):393–397
11.
go back to reference Shao ZM, Nguyen M, Barsky SH (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19(38):4337–4345 Shao ZM, Nguyen M, Barsky SH (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19(38):4337–4345
12.
go back to reference Tejada ML et al (2006) Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res 12(9):2676–2688 Tejada ML et al (2006) Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res 12(9):2676–2688
13.
go back to reference Gilbertson DG et al (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 276(29):27406–27414 Gilbertson DG et al (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 276(29):27406–27414
14.
go back to reference Li X et al (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2(5):302–309 Li X et al (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2(5):302–309
15.
go back to reference Campbell JS et al (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102(9):3389–3394 Campbell JS et al (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102(9):3389–3394
16.
go back to reference Borkham-Kamphorst E et al (2008) Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest 88(10):1090–1100 Borkham-Kamphorst E et al (2008) Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest 88(10):1090–1100
17.
go back to reference Anderberg C et al (2009) Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res 69(1):369–378 Anderberg C et al (2009) Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res 69(1):369–378
18.
go back to reference Maass T et al (2010) Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer 128:1259–1268 Maass T et al (2010) Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer 128:1259–1268
19.
go back to reference Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312 Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312
20.
go back to reference Beeser A et al (2005) Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem 280(44):36609–36615 Beeser A et al (2005) Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem 280(44):36609–36615
21.
go back to reference Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6(6):459–471 Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6(6):459–471
22.
go back to reference Machuy N et al. (2007) c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles. J Mol Biol 370(4):620–632 Machuy N et al. (2007) c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles. J Mol Biol 370(4):620–632
23.
go back to reference Hsu RM et al (2010) Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell 21(2):287–301 Hsu RM et al (2010) Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell 21(2):287–301
24.
go back to reference Coniglio SJ, Zavarella S, Symons MH (2008) Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol 28(12):4162–4172 Coniglio SJ, Zavarella S, Symons MH (2008) Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol 28(12):4162–4172
25.
go back to reference Yi C et al (2008) Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Res 68(19):7932–7937 Yi C et al (2008) Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Res 68(19):7932–7937
26.
go back to reference Parola M, Marra F, Pinzani M (2008) Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 29(1–2):58–66 Parola M, Marra F, Pinzani M (2008) Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 29(1–2):58–66
27.
go back to reference Bandapalli OR et al (2011) Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases. Anticancer Res 31(4):1215–1224 Bandapalli OR et al (2011) Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases. Anticancer Res 31(4):1215–1224
28.
go back to reference Wang Y, et al (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132–144 Wang Y, et al (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132–144
29.
go back to reference Xu L et al (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54(1):142–151 Xu L et al (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54(1):142–151
30.
go back to reference Joyce JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7(6):513–520 Joyce JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7(6):513–520
31.
go back to reference De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429–447 De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429–447
32.
go back to reference Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432(7015):332–337 Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432(7015):332–337
33.
go back to reference Rasanen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Exp Cell Res 316(17):2713–2722 Rasanen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Exp Cell Res 316(17):2713–2722
34.
go back to reference Kang N, Gores GJ, Shah VH (2011) Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54(2):707–713 Kang N, Gores GJ, Shah VH (2011) Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54(2):707–713
35.
go back to reference Olaso E et al (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26(3):634–642 Olaso E et al (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26(3):634–642
36.
go back to reference Olaso E et al (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37(3):674–685 Olaso E et al (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37(3):674–685
37.
go back to reference Paku S, Kopper L, Nagy P (2005) Development of the vasculature in “pushing-type” liver metastases of an experimental colorectal cancer. Int J Cancer 115(6):893–902 Paku S, Kopper L, Nagy P (2005) Development of the vasculature in “pushing-type” liver metastases of an experimental colorectal cancer. Int J Cancer 115(6):893–902
38.
go back to reference Faouzi S et al. (1999) Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 30(2):275–284 Faouzi S et al. (1999) Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 30(2):275–284
39.
go back to reference Mikula M et al (2006) Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209(2):560–567 Mikula M et al (2006) Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209(2):560–567
40.
go back to reference Amann T et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100(4):646–653 Amann T et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100(4):646–653
41.
go back to reference Rovida E et al (2008) ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J Hepatol 48(1):107–115 Rovida E et al (2008) ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J Hepatol 48(1):107–115
Metadata
Title
Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2
Authors
Obul R. Bandapalli
Stephan Macher-Goeppinger
Peter Schirmacher
Karsten Brand
Publication date
01-06-2012
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 5/2012
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-012-9459-3
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine